Protagonist Therapeutics' Series B - II Round

Protagonist Therapeutics raised a round of funding on September 19, 2013. Investors include Pharmstandard International.

Protagonist Therapeutics is a biotechnology company pursuing the discovery and development of target oral peptides as well differentiated alternatives to antibodies, and also as new chemical entities …

Articles about Protagonist Therapeutics' Series B - II Round: